Concerning our more detailed studies on EGFR mutations, these were found to be distributed unevenly across different histological subtypes in early-stage NSCLC, which in fact reflected the pattern observed in advanced NSCLC. This evidence concerns the gene EGFR and non-small cell lung carcinoma.